These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36716444)

  • 1. Mitochondria-Targeting Polyprodrugs to Overcome the Drug Resistance of Cancer Cells by Self-Amplified Oxidation-Triggered Drug Release.
    Mukerabigwi JF; Tang R; Cao Y; Mohammed F; Zhou Q; Zhou M; Ge Z
    Bioconjug Chem; 2023 Feb; 34(2):377-391. PubMed ID: 36716444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid/dextran-based polymeric micelles co-delivering ursolic acid and doxorubicin to mitochondria for potentiating chemotherapy in MDR cancer.
    Guo Y; Yang X; Zhang Y; Luo F; Yang J; Zhang X; Mi J; Xie Y
    Carbohydr Polym; 2024 May; 332():121897. PubMed ID: 38431408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-Targeting Polymeric Nanocarriers to Deliver ROS-Responsive Prodrugs and Combat Multidrug Resistance of Cancer Cells.
    Xi L; Wang J; Wang Y; Ge Z
    Macromol Biosci; 2021 Sep; 21(9):e2100091. PubMed ID: 34145971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles.
    Yu P; Yu H; Guo C; Cui Z; Chen X; Yin Q; Zhang P; Yang X; Cui H; Li Y
    Acta Biomater; 2015 Mar; 14():115-24. PubMed ID: 25498306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin derivative loaded acetal-PEG-PCCL micelles for overcoming multidrug resistance in MCF-7/ADR cells.
    Zhong XC; Xu WH; Wang ZT; Guo WW; Chen JJ; Guo NN; Wang TT; Lin MT; Zhang ZT; Lu YY; Yang QY; Han M; Xu DH; Gao JQ
    Drug Dev Ind Pharm; 2019 Sep; 45(9):1556-1564. PubMed ID: 31271317
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
    Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
    Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria and Nucleus Dual Delivery System To Overcome DOX Resistance.
    Cui H; Huan ML; Ye WL; Liu DZ; Teng ZH; Mei QB; Zhou SY
    Mol Pharm; 2017 Mar; 14(3):746-756. PubMed ID: 28146635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer.
    Liu HN; Guo NN; Guo WW; Huang-Fu MY; Vakili MR; Chen JJ; Xu WH; Wei QC; Han M; Lavasanifar A; Gao JQ
    Acta Pharmacol Sin; 2018 Oct; 39(10):1681-1692. PubMed ID: 29849132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctionalized Micelles Facilitate Intracellular Doxorubicin Delivery for Reversing Multidrug Resistance of Breast Cancer.
    Cao A; Ma P; Yang T; Lan Y; Yu S; Liu L; Sun Y; Liu Y
    Mol Pharm; 2019 Jun; 16(6):2502-2510. PubMed ID: 30998372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial Targeted Doxorubicin-Triphenylphosphonium Delivered by Hyaluronic Acid Modified and pH Responsive Nanocarriers to Breast Tumor: in Vitro and in Vivo Studies.
    Liu HN; Guo NN; Wang TT; Guo WW; Lin MT; Huang-Fu MY; Vakili MR; Xu WH; Chen JJ; Wei QC; Han M; Lavasanifar A; Gao JQ
    Mol Pharm; 2018 Mar; 15(3):882-891. PubMed ID: 29357260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ROS and GSH-responsive S-nitrosoglutathione functionalized polymeric nanoparticles to overcome multidrug resistance in cancer.
    Wu W; Chen M; Luo T; Fan Y; Zhang J; Zhang Y; Zhang Q; Sapin-Minet A; Gaucher C; Xia X
    Acta Biomater; 2020 Feb; 103():259-271. PubMed ID: 31846803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
    Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
    Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
    Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TME-Responsive Polyprodrug Micelles for Multistage Delivery of Doxorubicin with Improved Cancer Therapeutic Efficacy in Rodents.
    Zhang S; Zhu P; He J; Dong S; Li P; Zhang CY; Ma T
    Adv Healthc Mater; 2020 Sep; 9(18):e2000387. PubMed ID: 32815646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
    Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X
    Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Codelivery of doxorubicin and camptothecin by dual-responsive unimolecular micelle-based β-cyclodextrin for enhanced chemotherapy.
    Gao YE; Bai S; Ma X; Zhang X; Hou M; Shi X; Huang X; Chen J; Wen F; Xue P; Kang Y; Xu Z
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110428. PubMed ID: 31415956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial targeted doxorubicin derivatives delivered by ROS-responsive nanocarriers to breast tumor for overcoming of multidrug resistance.
    Zhong XC; Shi MH; Liu HN; Chen JJ; Wang TT; Lin MT; Zhang ZT; Zhou Y; Lu YY; Xu WH; Gao JQ; Xu DH; Han M; Chen YD
    Pharm Dev Technol; 2021 Jan; 26(1):21-29. PubMed ID: 33070673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance.
    Zhang J; Zhao X; Chen Q; Yin X; Xin X; Li K; Qiao M; Hu H; Chen D; Zhao X
    Acta Biomater; 2017 Mar; 50():381-395. PubMed ID: 27956367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional PLGA nanoparticles combining transferrin-targetability and pH-stimuli sensitivity enhanced doxorubicin intracellular delivery and in vitro antineoplastic activity in MDR tumor cells.
    Scheeren LE; Nogueira-Librelotto DR; Mathes D; Pillat MM; Macedo LB; Mitjans M; Vinardell MP; Rolim CMB
    Toxicol In Vitro; 2021 Sep; 75():105192. PubMed ID: 33984456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-Delivery of Paclitaxel and Doxorubicin by pH-Responsive Prodrug Micelles for Cancer Therapy.
    Jiang Y; Zhou Y; Zhang CY; Fang T
    Int J Nanomedicine; 2020; 15():3319-3331. PubMed ID: 32494132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.